GGrantIndex
Sort

326,823 grants matching clinical trial

Center for Research Improving Treatment of Drug Abuse

$2,347,979
University Of Pennsylvania · P60 · FY2004 · DA

Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial

$2,347,808
Sundeep Khosla · Mayo Clinic Rochester · R01 · FY2021 · AG

NSTN National Clinical Coordinating Center

$2,347,302
Joseph Paul Broderick · University Of Cincinnati · U01 · FY2015 · NS

Improving Uptake of Cervical Cancer Prevention Services in Appalachia

$2,346,919
Electra D. Paskett · Ohio State University · P01 · FY2021 · CA

Novel Insights Into Cerebral Ischemic Pathophysiology In Humans

$2,346,849
Lawrence Latour · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE

$2,346,815
Daniel William Cramer · Brigham And Women'S Hospital · P50 · FY2006 · CA

UCLA SPORE in Prostate Cancer

$2,346,813
Robert E Reiter · University Of California Los Angeles · P50 · FY2008 · CA

Pharmacogenomic Evaluation of Antihypertensive Responses

$2,346,440
Julie A. Johnson · University Of Florida · U01 · FY2009 · GM

SPORE in Brain Cancer

$2,346,429
Darell D Bigner · Duke University · P50 · FY2008 · CA

FSH - an Aging Hormone?

$2,346,376
Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AG

New Approaches to Tissue Repair

$2,346,294
Vincent Falanga · Roger Williams Hospital · P20 · FY2011 · RR

New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency

$2,346,142
Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2018 · HL

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,346,019
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2020 · DA

SPORE in Prostate Cancer

$2,345,974
Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

Program Project – Improving Provider Announcement Communication Training (IMPACT)

$2,345,967
Noel Todd Brewer · Univ Of North Carolina Chapel Hill · P01 · FY2022 · CA

Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa

$2,345,862
Diane V Havlir · University Of California, San Francisco · P01 · FY2016 · HD

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,345,590
Etta D Pisano · Univ Of North Carolina Chapel Hill · UL1 · FY2010 · RR

UCLA SPORE in Prostate Cancer

$2,345,450
Robert E Reiter · University Of California Los Angeles · P50 · FY2007 · CA

Epigenetic Therapies - New Approaches

$2,345,381
Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2023 · CA

Epigenetic Therapies - New Approaches

$2,345,381
Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2022 · CA

Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer

$2,345,277
Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2021 · CA

Lung Cancer Mutation Analysis

$2,345,250
Paul A Bunn · University Of Colorado Denver · RC2 · FY2010 · CA

Care partner-assisted ImplementatiOn of Patch HybrId Closed Loop Insulin Delivery for Older Adults with T1D (COPILOT)

$2,345,176
Robert J Henderson · Jaeb Center For Health Research, Inc. · R01 · FY2025 · DK

Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study

$2,345,103
Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2015 · AG

Pitt-Ohio State Clinical Trials Unit

$2,344,903
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2021 · AI